triazoles has been researched along with Coronary Restenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Gong, S; Guo, LW; Kent, KC; Shi, X; Urabe, G; Wang, B; Wang, Y; Xie, R | 1 |
| Ahn, BY; Cho, BJ; Choi, SH; Jang, HC; Kang, SM; Kim, YB; Lim, S; Park, HS; Park, KS; Shin, H; Yoon, JW | 1 |
2 other study(ies) available for triazoles and Coronary Restenosis
| Article | Year |
|---|---|
A paradigm of endothelium-protective and stent-free anti-restenotic therapy using biomimetic nanoclusters.
Topics: Animals; Azepines; Biomimetic Materials; Carotid Arteries; Carotid Artery Injuries; Coronary Restenosis; Drug-Eluting Stents; Endothelium, Vascular; Humans; Male; Nanoparticles; Neointima; Rats, Sprague-Dawley; Sirolimus; Triazoles | 2018 |
Effect of a dipeptidyl peptidase-IV inhibitor, des-fluoro-sitagliptin, on neointimal formation after balloon injury in rats.
Topics: Adiponectin; Administration, Oral; Animals; Blood Glucose; C-Reactive Protein; Carotid Arteries; Carotid Artery Injuries; Chemokine CCL2; Coronary Restenosis; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Plasminogen Activator Inhibitor 1; Pyrazines; Rats; Rats, Inbred OLETF; Sitagliptin Phosphate; Triazoles; Tumor Necrosis Factor-alpha; Tunica Intima | 2012 |